WO1995012132A1 - Object imaging using diffuse light - Google Patents
Object imaging using diffuse light Download PDFInfo
- Publication number
- WO1995012132A1 WO1995012132A1 PCT/US1994/012486 US9412486W WO9512132A1 WO 1995012132 A1 WO1995012132 A1 WO 1995012132A1 US 9412486 W US9412486 W US 9412486W WO 9512132 A1 WO9512132 A1 WO 9512132A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- photon density
- density waves
- diffuse photon
- diffuse
- wavelength
- Prior art date
Links
- 0 C*(C)(*)*CC=N Chemical compound C*(C)(*)*CC=N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4795—Scattering, i.e. diffuse reflection spatially resolved investigating of object in scattering medium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
- G01S17/00—Systems using the reflection or reradiation of electromagnetic waves other than radio waves, e.g. lidar systems
- G01S17/87—Combinations of systems using electromagnetic waves other than radio waves
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
- G01S17/00—Systems using the reflection or reradiation of electromagnetic waves other than radio waves, e.g. lidar systems
- G01S17/88—Lidar systems specially adapted for specific applications
- G01S17/89—Lidar systems specially adapted for specific applications for mapping or imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0091—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for mammography
Definitions
- This invention relates generally to imaging of objects. More specifically, this invention relates to methods and apparatus for imaging objects using diffuse light.
- Imaging techniques have been used for nearly a century in the medical arts for diagnosing and understanding the myriad diseases and maladies that afflict the human body. Imaging techniques have also found use in such diverse fields as radio astronomy, sonar, radar and other fields which require information about an object which is not readily visible to the naked eye and therefore not easily examined. Medical imaging techniques include, for example, X- ray imaging, positron emission tomography (PET) , ultrasound imaging and the well known magnetic resonance imaging (MRI) .
- PET positron emission tomography
- MRI magnetic resonance imaging
- narrow band frequency radiation illuminates the object of interest to produce reflected or emitted radiation which is then gathered from the object by a detector.
- the reflected or emitted radiation is then processed by an imaging algorithm to obtain useful information about the object.
- ionizing radiation in imaging involves significant health risks to a patient when the patient is exposed to the radiation for prolonged periods of time or in multiple imaging schemes.
- certain of these imaging techniques undesirably involve the use of invasive procedures which are both costly and painful.
- Yet other techniques such as MRI do not yield consistently useful clinical results.
- phase modulation techniques have permitted the location of single absorbers using low power, continuous wavelength lasers.
- an amplitude modulated source creates photon density waves that acquire anomalous phase shifts due to the absorber.
- the distortions are readily interpreted; however for a more complicated object a general analysis is required.
- Singer et al. usually require many iterations since the absorption or scattering values may not converge rapidly. Furthermore, the Singer et al. system utilizes cumbersome Monte-Carlo statistical techniques which consume large amounts of processing time without guaranteeing computational success. Singer et al. 's methods may also produce false local minima providing misleading results for the absorption characteristics. Thus prior imaging techniques using diffuse light for scattering fail to solve a long-felt need in the art for robust imaging techniques which can produce reliable images in biological systems. Solution of the aforementioned problems has heretofore eluded the medical imaging art.
- an imaging system comprises source means for generating oscillatory diffuse photon density waves to illuminate the object, detection means for detecting diffuse photon density waves produced as a result of the diffuse photon density waves interacting with the object, and processing means interfaced with the detection means for processing data corresponding to the photon density waves detected by the detection means to determine at least a position of the object.
- the turbid medium and the object have associated therewith at least one diffusion coefficient and the diffuse photon density waves which illuminate the object diffract around or refract through the object as a result of their interaction with it, thereby producing a distorted wavefront such that after the detection means detects the distorted wavefront the processing means determines the diffusion coefficient of the turbid medium and the object. More preferably, the processing means constructs phase- and amplitude contours corresponding to propagation of the distorted wavefront and further determines at least the position of the object from the phase and amplitude contours, thereby imaging the object.
- display means are interfaced with the processing means for displaying the image of the object, the source means comprises at least one laser, and the detection means comprises an optical fiber interfaced with a photomultiplier tube.
- the processing means can image the object.
- the source means preferably comprises a plurality of lasers oriented around the object which alternately irradiate the object with the diffuse photon density waves of the first wavelength to cause the object to fluoresce.
- the detection means comprises an optical fiber that is placed in proximity to the object and a photomultiplier tube interfaced to the optical fiber.
- the imaging system further comprises switch means interfaced with each of the plurality of lasers for alternately and sequentially turning on and off each laser, and radio frequency driving means interfaced through the switch means with the lasers for driving the lasers to produce the diffuse photon density waves of the first wavelength.
- the imaging system comprises a plurality of lasers each having a spatial location with respect to the object. Each laser is more preferably modulated at all times during imaging at a different frequency in a frequency range around a specified frequency, thereby producing a power spectrum associated with each spatial location around the object.
- Analysis means are provided interfaced with the detection means and the processing means for analyzing the power spectrums associated with each spatial location to determine the position of the object.
- the source means comprises a phased-array.
- the phased-array preferably comprises at least two lasers that are substantially one hundred and eighty degrees out of phase with each other, thereby producing the diffuse photon density waves having the first wavelength whic interfere destructively to produce an amplitude null line and a substantially one hundred and eighty degree phase shift across the null line equidistant from the lasers.
- the processing means can produce an image of the object in the turbid medium.
- Systems and methods provided in accordance with the present invention will provide efficient imaging of tumors and other maladies that effect human tissue. These systems will also prove to be much more economical to build when compared to prior imaging systems, since they will not require the complex machinery that is associated with prior imaging systems such as MRI. Furthermore, since the methods and apparatus provided in accordance with the present invention utilize diffuse light for imaging, more reliable images of tumors will be presented to the medical diagnostician or clinician so that cancerous tumors and other inhomogeneities in the tissue will be detected earlier and more readily. This holds the promise of saving lives and reducing the overall costs of medical care.
- Figure 1 is a schematic representation of an imaging system using diffuse light wherein scattering experiments with diffuse photon density waves occurs.
- Figure 2 depicts measured constant contours of diffuse photon density waves propagating through a turbid medium.
- Figure 3 depicts measured constant phase contours of diffuse photon density waves propagating through turbid media and refracting across a plane boundary between two turbid media with different light diffusion coefficients.
- Figure 4 is a graph of phase contours of diffuse photon density waves propagating through turbid media after refracting across a cylindrical boundary separating two turbid media wherein lensing effects are observed.
- Figure 5 is a schematic representation of a "time ⁇ sharing" system for imaging diffuse photon density waves re- radiated from a fluorescent object.
- Figures 6A is a graph of phase contours of the disturbance produced by a fiber point source in a turbid medium.
- Figure 6B is a graph of the absorption and emission characteristics of a fluorescent dye contained in a spherical shell within the turbid medium.
- Figure 6C is a graph of measured constant amplitude phase contours for diffuse photon density waves emitted from a source into a turbid medium, and re-radiated diffuse photon density waves.
- Figure 7 is a schematic representation of a
- frequency-encoded system for imaging diffuse photon density waves re-radiated from a fluorescent object.
- Figures 8A and 8B are schematic representations of "phased-array" scanning systems for imaging re-radiated diffuse photon density waves and graphs of the object's position in the turbid medium and a null line associated with the phased-array.
- Propagating disturbances are produced in a dense, turbid medium containing objects when amplitude modulated light sources are introduced into the turbid medium.
- human tissue such as breast tissue containing tumors
- an oscillatory light source introduces diffuse photon density waves (hereinafter referred to as "DPDW") in the turbid medium.
- DPDW diffuse photon density waves
- DPDW can be used in at least two ways to perform imaging.
- DPDW are introduced into a turbid medium and refracted through and diffracted around objects in the medium, thereby producing a distorted wavefront which can then be analyzed to yield useful information concerning at least a position and size of the object around which the DPDW have been refracted.
- the inventors have determined that by introducing fluorescence to the object, photons in the re-radiated DPDW will be emitted from the object at a shifted wavelength with respect to the original DPDW and the re-radiated DPDW then analyzed to determine at least the position of the fluorescent objects in the turbid medium.
- This is particularly useful for imaging of tumors since in prior, non-diffuse light imaging techniques fluorescent dyes which respond to various forms of radiation have typically been introduced into tumors, thereby yielding information about the location and size and nature of the tumor under examination.
- imaging tumors and objects in turbid media with diffuse light will in the future produce significant and effective images for diagnostic and clinical purposes.
- DPDW scalar, over-damped, traveling waves of light energy density, denoted U(r,t) . They propagate through any medium in which the transport of light energy density, U, is governed by the "diffusion equation, " which is
- D is the "diffusion coefficient" for the medium. This diffusion equation holds for a non-absorbing medium.
- optically turbid media include dense suspensions of micrometer-sized spheres, human tissue, paints, foams, and
- Intralipid a mixture of water, soybean oil and egg yolk.
- A is a constant
- r is the radial distance from the origin
- D is the diffusion coefficient for light in the medium
- ⁇ is the source modulation frequency
- k ( ⁇ /2D) 12 .
- Equation (1) When absorption is present, a similar solution to Equation (1) can be obtained, but the real and imaginary parts of the wave vector k are different and depend explicitly on the sample absorption length (as well as the photon random walk step for inverse scattering factor) .
- the macroscopic disturbance obeys a Helmholtz equation, and therefore has many properties that are normally associated with conventional electromagnetic radiation.
- DPDW display refraction, diffraction, and interference properties similar to those observed with conventional electromagnetic radiation propagating through media.
- an apparatus for imaging objects in a turbid medium is shown schematically in Figure 1.
- the object 10 may contain smaller objects such as tumors which must be characterized for clinical purposes.
- the dense turbid medium imaged is Intralipid, a polydisperse suspension of particles having an average diameter of -0.4 ⁇ m, but a relatively wide range of sizes (i.e., from -0.1 to -1.1 ⁇ ) .
- D light diffusion coefficient
- a large fish tank 20 (30 cm x 30 cm x 60 cm) is filled with this material.
- the absorption is very small, the suspensions in the Intralipid are dilute, and therefore the diffusion coefficient is inversely proportional to the Intralipid concentration.
- a source fiber 30 and detector fiber 40 are placed in proximity to object 10.
- the source light 30 is preferably derived from a 3-mW diode laser 35 operating at about 816 run.
- the diode laser 35 is amplitude modulated at 200 MHz by driver 50, and the position of the source fiber 30 is fixed.
- the detector fiber 40 is in detecting proximity to the object 10 and is further connected to a photomultiplier tube 60 on its other end.
- both the reference from the driver 50 and the detected signal are down-converted to 25 kHz by heterodyning with a second oscillator 70 to 200.025 MHz.
- Mixers 80 preferably combine the frequencies to produce the 25 kHz signals shown.
- the low-frequency signals are then measured using a lock-in amplifier 90.
- the phase shift (and ac amplitude) of the detected light is measured with respect to the source 30 at each point on a 0.5-cm square planar grid throughout the sample. Constant phase contours are then determined by linear interpolation of the grid data.
- the sensitivity of the apparatus shown in Figure 1 is about 10 5 . Since the signal amplitude decays by >e '2 ⁇ in one wavelength, the range of the apparatus is limited to slightly more than one wavelength. Nevertheless, it is possible to clearly distinguish the essential physical phenomena of the DPDW scattering through the object 10 with this apparatus.
- the contours are approximately circular, and their radii can therefore be extrapolated back to the source 30.
- the phase shift and the quantity lnl rU ac (rt) ⁇ as a function of radial distance from the source are plotted. From these measurements it is possible to determine that the wavelength of the DPDW is 11.2 cm, the photon transport mean free path is - 0.2 cm, and the photon absorption length is -52 cm in -0.5% Intralipid at 22°C. In this case, the photon absorption can be attributed almost entirely to water.
- refraction of the DPDW is shown in three ways: (1) when a plane, acrylic partition or (2) a cylindrical acrylic partition is placed in the tank to simulate a boundary, and (3) when no partition is in place so that the medium is homogeneous.
- constant phase contours exist at about every 20°.
- the lower medium 55 has a concentration, c 2 , - 1.0% and light diffusion coefficient D x .
- the upper medium 65 has a concentration, c u , - ⁇ 0.25% and light diffusion coefficient D u .
- the contours below boundary 45 shown at the 4 cm position on the y-axis, are just the homogeneous media contours without refraction. These contours are obtained before the partition is introduced.
- the contours above the boundary 45 are derived from the DPDW that are transmitted into the less concentrated medium.
- ⁇ u ⁇ 2 ⁇ D ⁇ D '1 ' 2 - ⁇ 1 ( c 1 /c u ) l/2 .
- Figure 3 explicitly demonstrates Snell's law for DPDW. This can be seen by following the ray from S 0 to the point A at the boundary 45, and then into the upper medium 65.
- the upper ray is constructed in the standard way between the apparent source position Si , through the point A on boundary 45, and into the medium 65 above the boundary.
- the inventors have also determined that by using a circular boundary (shown generally at 75 in Figure 4) to separate the two turbid media, the curvature of the DPDW can be altered in analogy with a simple lens in optics.
- a circular boundary shown generally at 75 in Figure 4
- two semi-infinite media are separated by curved boundary 75, and the medium 55 on the right is more concentrated.
- the constant phase contours of the transmitted wave exhibit a shorter wavelength, and are clearly converging toward some image point to the right of the boundary.
- the medium 65 on the left ( ⁇ ) has an Intralipid concentration of -0.1%
- the medium 55 on the right ( ⁇ r ) has a concentration of -1.6%.
- Equation (1) the differential from of Fick's law and photon flux conservation principles were used.
- the effects of absorption of the DPDW can be ignored, and it can be assumed that the time it takes for light to travel a single random walk step is much shorter than the modulation period.
- Equation (1) The spatial part of L7 ac (r,t) in Equation (1) is simply the Green's function solution of the Helmholtz equation with the appropriate k. Therefore, some of the basic theorems that apply to solutions of the Helmholtz equation will apply to DPDW propagation in a turbid medium. For example, a Kirchoff integral can be constructed for these waves using the Green's function solution. This provides a formal method by which to calculate the wave amplitude and phase at various distances from a "diffracting" aperture as has been discussed in this Part II. To the extent that the Kirchoff integral embodies the basic Huygens-Fresnel principle, contributions of different elements of a scattering surface arising from damped, spherical point sources will be observed.
- DPDW focusing of DPDW will have the same limitations due to diffraction as in the case of light propagating in a standard optical medium.
- imaging of tumor-like inhomogeneities in tissue can be accomplished in accordance with the present invention by examining the refractive, diftractive and scattering properties of DPDW incident to the tissue.
- examining re- radiated DPDW from a fluorescent inhomogeneity in a turbid medium provides methods of imaging inhomogeneities in the medium.
- Many types of tumors which occur in the human body comprise inhomogeneities which can be made to fluoresce after being irradiated with DPDW, and therefore, the inventors have determined that re-radiated DPDW provide an excellent means of locating tumors.
- the model biological material Intralipid is used.
- An amplitude modulated 200 MHz or 50 MHz laser diode -3mW, 780 nm is fiber-coupled into the medium, and another optical fiber is used to detect diffuse photons as a function of position within the medium.
- the phase and amplitude of the DPDW in the medium can be observed.
- a preferred apparatus for imaging inhomo- geneities in turbid media by detecting re-radiated DPDW is shown schematically in Figure 5.
- the absorber/radiator shown at 100 preferably comprises a shell filled with Intralipid at a concentration of 0.4mg/L Indocyanine green dye which is less than one tenth of the concentration commonly used in human subjects to test hepatic function.
- multiple sources 110 and a single detector 120 are used to determine the center of the fluorescent object 100.
- Computer processor 130 preferably outputs a control signal to switch 140 which controls the sequential activation of each of sources 110.
- a detector 150 which most preferably comprises a photomultiplier tube is interfaced both to detector fiber 120 and computer processor 130.
- detector 150 is a Hamamatsu R928 or Rl645u photomultiplier tube which also comprises a high voltage power supply that ensures adequate gain to computer 5 processor 130 so the computer processor 130 can process the data received from detector fiber 120.
- a display device 160 preferably a CRT screen, is interfaced to computer processor 130 and outputs an image 170 of object 100.
- the partial amplitude resulting solely from source i is dependent on the i th source-object separation, the quantum efficiency of the dye in the object 100, and the
- ⁇ is the quantum efficiency of the dye
- ri is the 25 position of the i th source
- r 0 is the position of the object center
- r d is the detector position
- k (k') is the wave vector magnitude of the DPDW at 780 nm (830 nm) .
- the individual sources 110 are separately turned on and off, and the re-radiated amplitude for each object separation is measured. Since the source positions r l 35 and the detector position r d are known, it is possible to estimate the object's position by finding the value of r 0 that gives the best agreement with the measured ratio I u /I TJ D -I . Generally, three sources 110 are necessary to localize the 40 object in two dimensions.
- re-radiated DPDW are obtained by filling a spherical glass shell with the absorbing dye Indocyanine green, and then illuminating the sphere with DPDW in the Intralipid solution.
- the dye is preferably chosen to absorb radiation at the source wavelength of 780 nm, and very soon thereafter re-radiate photons at a red-shifted energy, 830 nm. Because the dye has a lifetime of less than 1 nsec compared to the 5nsec period of the source, the re-radiated energy is in the form of a DPDW at the red-shifted energy.
- the absorption and emission characteristics of the dye are shown in Figure 6B wherein the inset is the chemical formula of the dye material.
- the Intralipid solution surrounding the obstacle has a concentration of 0.1% giving a source diffuse photon density wavelength of -18 cm.
- a point source at the origin generates the incident DPDW.
- Constant amplitude contours of the incident wave in the presence of the obstacle are shown in Figure 6C (dashed lines) .
- two spectral filters centered on 830 nm Schott glass filters, RG830
- RG830 are provided to enable the incident and re-radiated DPDW to be separated.
- the measured constant amplitude contours of the wave at 830 nm are shown as solid lines, and the measured incident amplitude contours at 780 nm are shown as dashed lines.
- the dashed lines demonstrate the DPDW character of the re-radiated waves.
- the re-radiated wave originates from within the absorbing object.
- the DPDW wavelength at 830 nm is somewhat longer than the DPDW wavelength at 780 nm. This is a function of the relatively larger diffusion coefficient for 830 nm light in Intralipid.
- a type of fluorescence of DPDW has occurred and the inhomogeneity is converted into a source of secondary DPDW.
- f i i.e., 200.00 + k (.01) MHz
- a modulation power spectrum is associated with each spatial location in the sample.
- FIG. 8A and 8B A third, alternative embodiment for imaging fluorescent objects that re-radiate DPDW is shown in Figures 8A and 8B.
- the apparatus of Figures 8A and 8B is qualitatively different than the time-sharing apparatus and frequency encoded apparatus of Figures 5 and 7 respectively, since it uses a scanning phased-array 190 and a single detector 200.
- the phased-array 190 comprises two sources 85 and 95 that are substantially 180° out of phase with each other and that emit DPDW which interfere destructively to produce an amplitude null and a sharp 180° phase shift across a curve that describes this family of points called the "null line,” shown schematically at 210.
- the object 220 By placing a detector 200 on the null line 210, and then moving an absorbing object 220 from one side of the null line 210 to the other, the object 220 will preferentially absorb light from the nearest source, and therefore distort the null line.
- the absorber 220 is also a re-radiator, the complimentary effect is seen, that is, the object re- radiates more light derived from the closest source.
- the phase of the detected DPDW will undergo a 180° shift as the absorber crosses the original, undisturbed null line 210.
- the phase shift of the re-radiated light is always the same, independent of detector position.
- the techniques and apparatus of the present invention provide particularly powerful clinical tools for imaging, locating and sizing tumors in human tissue.
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Electromagnetism (AREA)
- Chemical & Material Sciences (AREA)
- Radar, Positioning & Navigation (AREA)
- Computer Networks & Wireless Communication (AREA)
- Life Sciences & Earth Sciences (AREA)
- Remote Sensing (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Optics & Photonics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Escalators And Moving Walkways (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7512886A JPH09504964A (en) | 1993-10-29 | 1994-10-31 | Object imaging using diffused light |
EP95900484A EP0727053A4 (en) | 1993-10-29 | 1994-10-31 | Object imaging using diffuse light |
US08/637,645 US5917190A (en) | 1993-10-29 | 1994-10-31 | Object imaging using diffuse light |
AU81294/94A AU700802B2 (en) | 1993-10-29 | 1994-10-31 | Object imaging using diffuse light |
US08/783,682 US6304771B1 (en) | 1993-10-29 | 1997-01-15 | Systems and methods for imaging fluorophores |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14546693A | 1993-10-29 | 1993-10-29 | |
US08/145,466 | 1993-10-29 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/783,682 Continuation-In-Part US6304771B1 (en) | 1993-10-29 | 1997-01-15 | Systems and methods for imaging fluorophores |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995012132A1 true WO1995012132A1 (en) | 1995-05-04 |
Family
ID=22513255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1994/012486 WO1995012132A1 (en) | 1993-10-29 | 1994-10-31 | Object imaging using diffuse light |
Country Status (6)
Country | Link |
---|---|
US (1) | US5917190A (en) |
EP (1) | EP0727053A4 (en) |
JP (1) | JPH09504964A (en) |
AU (1) | AU700802B2 (en) |
CA (1) | CA2175348A1 (en) |
WO (1) | WO1995012132A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998007021A1 (en) * | 1996-08-14 | 1998-02-19 | Philips Electronics N.V. | Device for and method of forming an image of a turbid medium |
US5747810A (en) * | 1995-05-15 | 1998-05-05 | Univ. Of Pennsylvania | Simultaneous absorption and diffusion tomography system and method using direct reconstruction of scattered radiation |
EP0846262A1 (en) * | 1995-08-24 | 1998-06-10 | Purdue Research Foundation | Fluorescence lifetime-based imaging and spectroscopy in tissues and other random media |
US5832922A (en) * | 1995-05-15 | 1998-11-10 | Schotland; John Carl | Diffusion Tomography system and method using direct reconstruction of scattered radiation |
US7006676B1 (en) | 2000-01-21 | 2006-02-28 | Medical Optical Imaging, Inc. | Method and apparatus for detecting an abnormality within a host medium utilizing frequency-swept modulation diffusion tomography |
US7054002B1 (en) | 1999-10-08 | 2006-05-30 | The Texas A&M University System | Characterization of luminescence in a scattering medium |
EP1729261A1 (en) | 2005-06-01 | 2006-12-06 | Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts | Method for tomographic reconstruction |
US7187441B1 (en) | 1996-11-08 | 2007-03-06 | The Texas A&M University System | Particle analysis system and method |
US7328059B2 (en) | 1996-08-23 | 2008-02-05 | The Texas A & M University System | Imaging of light scattering tissues with fluorescent contrast agents |
US7599732B2 (en) | 2003-06-20 | 2009-10-06 | The Texas A&M University System | Method and system for near-infrared fluorescence contrast-enhanced imaging with area illumination and area detection |
US7865230B1 (en) | 1997-02-07 | 2011-01-04 | Texas A&M University System | Method and system for detecting sentinel lymph nodes |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6304771B1 (en) * | 1993-10-29 | 2001-10-16 | The Trustees Of The University Of Pennsylvania | Systems and methods for imaging fluorophores |
US6649143B1 (en) * | 1994-07-01 | 2003-11-18 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive localization of a light-emitting conjugate in a mammal |
US7255851B2 (en) * | 1994-07-01 | 2007-08-14 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive localization of a light-emitting conjugate in a mammal |
US6525862B2 (en) * | 1996-10-30 | 2003-02-25 | Photogen, Inc. | Methods and apparatus for optical imaging |
US6597931B1 (en) | 2000-09-18 | 2003-07-22 | Photonify Technologies, Inc. | System and method for absolute oxygen saturation |
US6801648B2 (en) | 2000-08-04 | 2004-10-05 | Xuefeng Cheng | Optical imaging system with symmetric optical probe |
US6587703B2 (en) | 2000-09-18 | 2003-07-01 | Photonify Technologies, Inc. | System and method for measuring absolute oxygen saturation |
US6516209B2 (en) | 2000-08-04 | 2003-02-04 | Photonify Technologies, Inc. | Self-calibrating optical imaging system |
US7403812B2 (en) | 2001-05-17 | 2008-07-22 | Xenogen Corporation | Method and apparatus for determining target depth, brightness and size within a body region |
US7599731B2 (en) * | 2002-07-16 | 2009-10-06 | Xenogen Corporation | Fluorescent light tomography |
US7616985B2 (en) * | 2002-07-16 | 2009-11-10 | Xenogen Corporation | Method and apparatus for 3-D imaging of internal light sources |
US7087075B2 (en) * | 2002-09-30 | 2006-08-08 | Medtronic Emergency Response Systems, Inc. | Feedback system for rapid induction of mild hypothermia |
US20040064169A1 (en) * | 2002-09-30 | 2004-04-01 | Briscoe Kathleen E. | User interface for medical device |
US7056282B2 (en) * | 2002-12-23 | 2006-06-06 | Medtronic Emergency Response Systems, Inc. | Coolant control for rapid induction of mild hypothermia |
US20050027173A1 (en) * | 2003-07-31 | 2005-02-03 | Briscoe Kathleen E. | Brain injury protocols |
US7991242B2 (en) | 2005-05-11 | 2011-08-02 | Optosecurity Inc. | Apparatus, method and system for screening receptacles and persons, having image distortion correction functionality |
US20090174554A1 (en) | 2005-05-11 | 2009-07-09 | Eric Bergeron | Method and system for screening luggage items, cargo containers or persons |
JP2009516849A (en) * | 2005-11-23 | 2009-04-23 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Method and device for imaging inside a turbid medium |
US7899232B2 (en) | 2006-05-11 | 2011-03-01 | Optosecurity Inc. | Method and apparatus for providing threat image projection (TIP) in a luggage screening system, and luggage screening system implementing same |
US8494210B2 (en) | 2007-03-30 | 2013-07-23 | Optosecurity Inc. | User interface for use in security screening providing image enhancement capabilities and apparatus for implementing same |
US10335038B2 (en) | 2006-08-24 | 2019-07-02 | Xenogen Corporation | Spectral unmixing for in-vivo imaging |
US10775308B2 (en) | 2006-08-24 | 2020-09-15 | Xenogen Corporation | Apparatus and methods for determining optical tissue properties |
US8620051B2 (en) * | 2006-12-22 | 2013-12-31 | Salim Djerizi | Registration of optical images of turbid media |
HU229699B1 (en) * | 2007-05-23 | 2014-05-28 | Mta Termeszettudomanyi Kutatokoezpont Mta Ttk | Imaging optical checking device with pinhole camera (reflectometer, polarimeter, ellipsicmeter) |
US9775545B2 (en) | 2010-09-28 | 2017-10-03 | Masimo Corporation | Magnetic electrical connector for patient monitors |
US8821397B2 (en) | 2010-09-28 | 2014-09-02 | Masimo Corporation | Depth of consciousness monitor including oximeter |
AU2012304490B2 (en) | 2011-09-07 | 2015-06-25 | Rapiscan Systems, Inc. | X-ray inspection system that integrates manifest data with imaging/detection processing |
US10154815B2 (en) | 2014-10-07 | 2018-12-18 | Masimo Corporation | Modular physiological sensors |
US9964485B2 (en) * | 2015-09-03 | 2018-05-08 | National Cheng Kung University | Optical device and method for determining an optical property of specimen |
US10302807B2 (en) | 2016-02-22 | 2019-05-28 | Rapiscan Systems, Inc. | Systems and methods for detecting threats and contraband in cargo |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3700801A (en) * | 1966-10-03 | 1972-10-24 | Trw Inc | Image analysis and correlation system and method |
JPS62124443A (en) * | 1985-11-26 | 1987-06-05 | Hamamatsu Photonics Kk | Device for obtaining information on inside of body with light |
US5022757A (en) * | 1989-01-23 | 1991-06-11 | Modell Mark D | Heterodyne system and method for sensing a target substance |
US5070455A (en) * | 1989-11-22 | 1991-12-03 | Singer Imaging, Inc. | Imaging system and method using scattered and diffused radiation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5353799A (en) * | 1991-01-22 | 1994-10-11 | Non Invasive Technology, Inc. | Examination of subjects using photon migration with high directionality techniques |
-
1994
- 1994-10-31 US US08/637,645 patent/US5917190A/en not_active Expired - Lifetime
- 1994-10-31 EP EP95900484A patent/EP0727053A4/en not_active Withdrawn
- 1994-10-31 WO PCT/US1994/012486 patent/WO1995012132A1/en not_active Application Discontinuation
- 1994-10-31 CA CA002175348A patent/CA2175348A1/en not_active Abandoned
- 1994-10-31 AU AU81294/94A patent/AU700802B2/en not_active Ceased
- 1994-10-31 JP JP7512886A patent/JPH09504964A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3700801A (en) * | 1966-10-03 | 1972-10-24 | Trw Inc | Image analysis and correlation system and method |
JPS62124443A (en) * | 1985-11-26 | 1987-06-05 | Hamamatsu Photonics Kk | Device for obtaining information on inside of body with light |
US5022757A (en) * | 1989-01-23 | 1991-06-11 | Modell Mark D | Heterodyne system and method for sensing a target substance |
US5070455A (en) * | 1989-11-22 | 1991-12-03 | Singer Imaging, Inc. | Imaging system and method using scattered and diffused radiation |
Non-Patent Citations (1)
Title |
---|
See also references of EP0727053A4 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747810A (en) * | 1995-05-15 | 1998-05-05 | Univ. Of Pennsylvania | Simultaneous absorption and diffusion tomography system and method using direct reconstruction of scattered radiation |
US5832922A (en) * | 1995-05-15 | 1998-11-10 | Schotland; John Carl | Diffusion Tomography system and method using direct reconstruction of scattered radiation |
EP0846262A1 (en) * | 1995-08-24 | 1998-06-10 | Purdue Research Foundation | Fluorescence lifetime-based imaging and spectroscopy in tissues and other random media |
EP0846262A4 (en) * | 1995-08-24 | 1999-11-03 | Purdue Research Foundation | Fluorescence lifetime-based imaging and spectroscopy in tissues and other random media |
WO1998007021A1 (en) * | 1996-08-14 | 1998-02-19 | Philips Electronics N.V. | Device for and method of forming an image of a turbid medium |
US7328059B2 (en) | 1996-08-23 | 2008-02-05 | The Texas A & M University System | Imaging of light scattering tissues with fluorescent contrast agents |
US7187441B1 (en) | 1996-11-08 | 2007-03-06 | The Texas A&M University System | Particle analysis system and method |
US7865230B1 (en) | 1997-02-07 | 2011-01-04 | Texas A&M University System | Method and system for detecting sentinel lymph nodes |
US7054002B1 (en) | 1999-10-08 | 2006-05-30 | The Texas A&M University System | Characterization of luminescence in a scattering medium |
US7006676B1 (en) | 2000-01-21 | 2006-02-28 | Medical Optical Imaging, Inc. | Method and apparatus for detecting an abnormality within a host medium utilizing frequency-swept modulation diffusion tomography |
US7599732B2 (en) | 2003-06-20 | 2009-10-06 | The Texas A&M University System | Method and system for near-infrared fluorescence contrast-enhanced imaging with area illumination and area detection |
EP1729261A1 (en) | 2005-06-01 | 2006-12-06 | Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts | Method for tomographic reconstruction |
Also Published As
Publication number | Publication date |
---|---|
CA2175348A1 (en) | 1995-05-04 |
AU8129494A (en) | 1995-05-22 |
EP0727053A4 (en) | 1998-04-01 |
US5917190A (en) | 1999-06-29 |
JPH09504964A (en) | 1997-05-20 |
EP0727053A1 (en) | 1996-08-21 |
AU700802B2 (en) | 1999-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5917190A (en) | Object imaging using diffuse light | |
US6304771B1 (en) | Systems and methods for imaging fluorophores | |
US9964747B2 (en) | Imaging system and method for imaging an object | |
US5213105A (en) | Frequency domain optical imaging using diffusion of intensity modulated radiation | |
US5528365A (en) | Methods and apparatus for imaging with diffuse light | |
US7804075B2 (en) | Method and system for tomographic imaging using fluorescent proteins | |
US8103329B2 (en) | System and method for imaging based on ultrasonic tagging of light | |
Colak et al. | Clinical optical tomography and NIR spectroscopy for breast cancer detection | |
JP3745775B2 (en) | Optical techniques for biological tissue examination. | |
O'Leary et al. | Reradiation and imaging of diffuse photon density waves using fluorescent inhomogeneities | |
US7823215B2 (en) | Molecular imaging and nanophotonics imaging and detection principles and systems, and contrast agents, media makers and biomarkers, and mechanisms for such contrast agents | |
US5807263A (en) | Imaging of biological tissue using photon migration with high directionality techniques | |
WO2005089637A9 (en) | Method and system for tomographic imaging using fluorescent proteins | |
EP2459987A1 (en) | Imaging device and method for optoacoustic imaging of small animals | |
EP2527815A1 (en) | Imaging device and method for optoacoustic or thermoacoustic imaging of small animals | |
US7692160B2 (en) | Method and system of optical imaging for target detection in a scattering medium | |
Turchin | Methods of biomedical optical imaging: from subcellular structures to tissues and organs | |
JP3958798B2 (en) | Imaging of light scattering tissue using fluorescent contrast agent | |
EP1797818A2 (en) | Method and system for tomographic imaging using fluorescent proteins | |
Zhu et al. | Combined ultrasound and near infrared diffused light imaging in a test object | |
Maier et al. | Frequency-domain methods in optical tomography: detection of localized absorbers and a backscattering reconstruction scheme | |
Liu et al. | 2D phased array fluorescence wireless localizer in breast cancer detection | |
CN211962001U (en) | Hyperspectral deep three-dimensional scattered light imager | |
Vo-Dinh | Ultrasonically Modulated Optical Imaging | |
Freiberger et al. | 3D Optical Imaging of Fluorescent Agents in Biological Tissues |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2175348 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1995900484 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08637645 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1995900484 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1995900484 Country of ref document: EP |